Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Lina Matta"'
Autor:
Teryl K. Nuckols MD, MSHS, Carl T. Berdahl MD, MS, Andrew J. Henreid MPH, Jeffrey L. Schnipper MD, MPH, Asad Rauf MD, EunJi M. Ko PharmD, An T. Nguyen OTD, Zoe Co BS, John Fanikos RPh, MBA, Ji-Hyun Kim PharmD, Donna W. Leang PharmD, Lina Matta PharmD, MPH, Kathleen Mulligan BA, Avik Ray MD, MS, Rita Shane PharmD, Kirollos Wassef PharmD, Joshua M. Pevnick MD, MSHS
Publikováno v:
Inquiry: The Journal of Health Care Organization, Provision, and Financing, Vol 60 (2023)
Optimal medication management is important during hospitalization and at discharge because post-discharge adverse drug events (ADEs) are common, often preventable, and contribute to patient harms, healthcare utilization, and costs. Conduct a cost ana
Externí odkaz:
https://doaj.org/article/f66da82bac7d4fc59c454703fe55126e
Autor:
Lauren N. Inglis, Darren M. Triller, Allison E. Burnett, Jessica Grandoni, Lina Matta, Katelyn Sylvester, William E. Dager, Michael P. Gulseth, John Fanikos
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6:117-126
Autor:
Anton Dodek, Mark D. Benson, Christopher P. Cannon, Benjamin M. Scirica, Calum A. MacRae, Tiffany V. Bui, Lina Matta, Kira Chaney, David Zelle, Jorge Plutzky, Michael Kraft, Akshay S. Desai, Marian McPartlin, Thomas A. Gaziano
Publikováno v:
American Heart Journal. 243:15-27
BACKGROUND Implementation of guideline-directed cholesterol management remains low despite definitive evidence establishing such measures reduce cardiovascular (CV) events, especially in high atherosclerotic CV disease (ASCVD) risk patients. Modern e
Autor:
Alexander J Blood, Thomas A. Gaziano, Liliana E. Fera, Katelyn V. Smith, Jacqueline R. Dunning, Kavishwar B. Wagholikar, Benjamin M. Scirica, Shawn N. Murphy, Ana A. Mercurio-Pinto, Lina Matta, Samuel J. Aronson, Joshua W. Bosque-Hamilton, Christina M. Fischer, Akshay S. Desai, Taylor E. MacLean, Calum A. MacRae
Publikováno v:
Clinical Cardiology
Although optimal pharmacological therapy for heart failure with reduced ejection fraction (HFrEF) is carefully scripted by treatment guidelines, many eligible patients are not treated with guideline‐directed medical therapy (GDMT) in clinical pract
Autor:
Lina Matta, Kavi B. Wagholikar, Calum A. MacRae, Hunter Nichols, William J. Gordon, Shawn N. Murphy, David Zelle, Christopher P. Cannon, Naomi D.L. Fisher, Angela Miller, Benjamin M. Scirica, Kira Chaney, Jorge Plutzky, Thomas A. Gaziano
Publikováno v:
Circulation
Autor:
Benjamin M. Scirica, Layne Ainsworth, Thomas A. Gaziano, Eloy Toscano, Shawn N. Murphy, Christina M. Fischer, Brent Richter, Kavishwar B. Wagholikar, Taylor E. MacLean, Calum A. MacRae, Liliana E. Fera, Joshua W. Bosque-Hamilton, Samuel J. Aronson, Jacqueline R. Dunning, Michael Oates, Akshay S. Desai, Katelyn V. Smith, Alyssa P. Goodson, Christopher Herrick, Lina Matta
Publikováno v:
Journal of Clinical Medicine Research
Background: The conventional approach for clinical studies is to identify a cohort of potentially eligible patients and then screen for enrollment. In an effort to reduce the cost and manual effort involved in the screening process, several studies h
Autor:
Mary P Kovacevic, Lina Matta, Michael Cotugno, Tom Cooley, John Fanikos, Heather Dell’Orfano, Yazed S Alsowaida, Caryn Belisle
Publikováno v:
Hosp Pharm
Background: Executive Quality and Safety WalkRounds (EWRs) is a tool that engages department leadership in discussion with the front-line employees to solicit feedback to improve quality and safety. The purpose of this study was to evaluate the impac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::774ceb2f9d206d81fd6d533ba0c2f77a
https://europepmc.org/articles/PMC9117781/
https://europepmc.org/articles/PMC9117781/
Autor:
Jacqueline R. Dunning, Joshua W. Bosque-Hamilton, Liliana E. Fera, David Zelle, Katelyn V. Smith, Taylor E. MacLean, Calum A. MacRae, Jamaal Y Grant, Christina M. Fischer, Benjamin M. Scirica, Thomas A. Gaziano, Lina Matta, Akshay S. Desai
Publikováno v:
Journal of pharmacy practice. 35(5)
Background: Although strategies for optimization of pharmacologic therapy in patients with heart failure with reduced ejection fraction (HFrEF) are scripted by guidelines, data from HF registries suggests that guideline-directed medical therapies (GD
Autor:
Julie Kelly, Maryam Alobaidly, Muthiah Vaduganathan, Megan N. Rhoten, Bryan M. Cook, Lina Matta, Parth N Patel, Jonathan W. Cunningham, Thomas D Bernier, Leo F. Buckley, Danielle M. Knowles, Alea Moscone, Jillian Dempsey, Lauren Sinnenberg, Rhynn Malloy, Krishan Sharma, Catherine Ulbricht, Niteesh K. Choudhry, Mary G. Amato, Mahan Nekoui, Caroline A. Snyder, Anubodh S. Varshney, Kenneth Lupi, Clara Ting, Erin E. McElrath, Ankeet S. Bhatt, Dale Adler, Karola S. Jering
Publikováno v:
European journal of heart failureReferences. 23(7)
AIMS Implementation of guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) remains incomplete. Non-cardiovascular hospitalization may present opportunities for GDMT optimization. We assessed the efficacy
Autor:
Lina Matta, John Fanikos, Paul M. Szumita, Loay Milibari, Caryn Belisle, Jon B. Silverman, Michael Cotugno, Charles A. Morris, Joshua C Vacanti, Tom Cooley, John Ryan Stackhouse, Megan A. Rocchio, Daniel A Sylvia, Peter Vo, Eric Goralnick, Angela Triggs
Publikováno v:
American Journal of Health-System Pharmacy: AJHP
Purpose Management of an acute shortage of parenteral opioid products at a large hospital through prescribing interventions and other guideline-recommended actions is described. Summary In early 2018, many hospitals were faced with a shortage of pare